Delivery Order SPE2DB22D3004-SPE2DB24FPN41
- Not listed
- This federal contract award, valued at $1,129.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the procurement of Pfizer COVID-19 vaccines, with a period of performance from February 2025 to March 2025. The contract is a firm fixed-price arrangement and was not designated as a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
- This federal contract award from the Defense Logistics Agency (DLA) is a $6,552.36 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Pfizer COVID-19 vaccines in 0.9mL doses. The award has an ultimate completion date of November 27, 2024 and is not designated as a set-aside contract. AmerisourceBergen maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award, valued at $1,642.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pfizer COVID-19 vaccines, with an ultimate completion date of November 19, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is a Child contract under a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award, valued at $2,149.73, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
- This federal contract award, valued at $3,407.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is a Delivery Order for the procurement of Pfizer COVID-19 vaccines for the 2024-2025 timeframe, with a period of performance through November 18, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designations, indicating open competition. AmerisourceBergen holds a significant Indefinite...
- This federal contract award, valued at $1,092.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products...
- This federal contract award, worth $1,081.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Pfizer COVID-19 vaccines in 0.9 mL doses, with a period of performance from January 2023 to January 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,100.15 Firm Fixed Price delivery order is for the supply of Pfizer COVID-19 vaccines and related medical products from 2024 to 2025, with a potential performance period of up to 4 years. The contract is not set aside and was openly competed. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award is a $1,100.15 firm-fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Pfizer's COVID-19 vaccine, with a performance period extending from June 2024 to June 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award is for the delivery of Pfizer COVID-19 vaccines to support the U.S. government's pandemic response efforts. The $1,622.03 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of February 19, 2025 and does not utilize a set-aside designation, indicating open competition. Amerisourcebergen...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPN41Delivery Order
This federal contract award, valued at $1,081.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pfizer COVID-19 vaccines in 0.9 mL doses, with an ultimate completion date of March 4, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not utilize any set-aside designations, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 3/1/24 |